GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 62 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 2.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $2,000 | -60.0% | 557 | -77.4% | 0.00% | – |
Q1 2021 | $5,000 | -70.6% | 2,462 | -67.0% | 0.00% | – |
Q4 2020 | $17,000 | +240.0% | 7,454 | +317.1% | 0.00% | – |
Q3 2020 | $5,000 | -68.8% | 1,787 | -66.0% | 0.00% | – |
Q2 2020 | $16,000 | -33.3% | 5,263 | -56.8% | 0.00% | – |
Q1 2020 | $24,000 | +4.3% | 12,195 | +51.9% | 0.00% | – |
Q4 2019 | $23,000 | +187.5% | 8,029 | +267.1% | 0.00% | – |
Q3 2019 | $8,000 | -78.4% | 2,187 | -75.8% | 0.00% | – |
Q2 2019 | $37,000 | -87.6% | 9,034 | -84.5% | 0.00% | – |
Q1 2019 | $298,000 | – | 58,373 | +30461.8% | 0.00% | – |
Q1 2016 | $0 | -100.0% | 191 | -85.6% | 0.00% | – |
Q4 2015 | $2,000 | -50.0% | 1,325 | +20.7% | 0.00% | – |
Q1 2015 | $4,000 | -63.6% | 1,098 | -66.0% | 0.00% | – |
Q4 2014 | $11,000 | +10.0% | 3,232 | +65.9% | 0.00% | – |
Q3 2014 | $10,000 | +400.0% | 1,948 | +1181.6% | 0.00% | – |
Q2 2014 | $2,000 | -71.4% | 152 | -64.7% | 0.00% | – |
Q1 2014 | $7,000 | +250.0% | 431 | +82.6% | 0.00% | – |
Q4 2013 | $2,000 | – | 236 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cutter & CO Brokerage, Inc. | 129,488 | $248,617 | 0.07% |
Geneos Wealth Management Inc. | 417,350 | $801,312 | 0.04% |
SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $23,040 | 0.02% |
RETIREMENT GUYS FORMULA LLC | 11,500 | $22,080 | 0.02% |
Vivaldi Capital Management LP | 19,261 | $36,981 | 0.01% |
OSAIC HOLDINGS, INC. | 3,275,192 | $6,288,345 | 0.01% |
Traynor Capital Management, Inc. | 34,707 | $66,638 | 0.01% |
Atria Wealth Solutions, Inc. | 259,800 | $498,816 | 0.01% |
BARRETT & COMPANY, INC. | 4,984 | $9,569 | 0.01% |
Wealthspire Advisors, LLC | 183,862 | $353,016 | 0.01% |